Your browser doesn't support javascript.
loading
Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy.
Im, Ji Hye; Kang, Keon Wook; Kim, Sun Young; Kim, Yoon Gyoon; An, Yong Jin; Park, Sunghyouk; Jung, Byung Hwa; Choi, Song-Yi; Lee, Jin-Sun; Kang, Keon Wook.
Affiliation
  • Im JH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Kang KW; Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea.
  • Kim SY; College of Pharmacy, Dankook University, Cheonan-si, Republic of Korea.
  • Kim YG; College of Pharmacy, Dankook University, Cheonan-si, Republic of Korea.
  • An YJ; Natural Product Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Park S; Natural Product Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Jung BH; Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
  • Choi SY; College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Lee JS; College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Kang KW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. kwkang@snu.ac.kr.
J Exp Clin Cancer Res ; 41(1): 176, 2022 May 17.
Article in En | MEDLINE | ID: mdl-35581622
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Exp Clin Cancer Res Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Exp Clin Cancer Res Year: 2022 Document type: Article